test 1: lecture 13 Flashcards

1
Q

⍺1 adrenergic agonists will cause — in the heart

A

nothing, no ⍺1 receptors in the heart

phenylephrine (Neo-Synephrine), oxymetazoline (Dristan), tetrahydrozoline (Visine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are some ⍺1 adrenergic agonists

A

phenylephrine (Neo-Synephrine), oxymetazoline (Dristan), tetrahydrozoline (Visine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what will ⍺1 adrenergic agnosists due to vasculature

A

vasoconstriction

this will trigger vagal effect and bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

phenylephrine (Neo-Synephrine) is used for —
tetrahydrozoline (Visine) is used for —

A

nasal decongestant
eye redness

both are ⍺1 adrenergic agonists that cause vasocontriction and then vagal reflex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Activation of presynaptic α2 receptor causes —

A

decreased NE release from neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clonidine (catapres) is a —

A

⍺2 adrenergic agonist → causes hypotension

binds to presynaptic ⍺2 receptor and causes decrease in NE release

will also attach to autoreceptors within the CNS, that will decrease SYM outflow to periphery

Also stimulate postsynaptic α2 receptors in periphery on VSMC → vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are two ⍺2 adrenergic agonists?

A

clonidine
xylazine

cause decreased NE release, decreased SYM outflow in the brain, cause vasoconstriction on vascular smooth muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Postsynaptic α2 receptor activation on VSMC in certain vascular beds result in — and a potential increase in —

A

vasoconstriction
BP

clonidine(catapres) and xlyazine (rompun) are ⍺2 adrenergic agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

biphasic response of ⍺2 adrenergic agnoists

A

brief initial pressor (hypertensive) effect that is gradually reverses to hypotension

2B postsynaptic ⍺2 receptors on VSMC cause inital vasoconstriction→HTN

2A ⍺2 activation in the CNS reduces SYM tone causing low BP

2A ⍺2 activation of the presynaptic receptor located on peripheral sympathetic nerve terminals innervating vascular smooth muscle augments vasodilation

drug used to treat HTN

clonidine (catapres)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

xylazine

A

⍺2 agonist that causes sedation and analgesia

because it binds to a2 receptors in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is rebound hypertension from a2 agonists

A

a2 on nerve stops NE release, smooth muscle cell increases receptors looking for NE, when you stop drug the extra receptors lead to bigger response

= vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

rebound effect of a1 agonists

A

nasal spray

chronic use of a1 agonist, will cause decrease in a1 receptors. if you stop drug quickly, normal amount of NE will be released but there is now lower # of a1 receptors. This leads to leaky vessels and nasal congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

nonselective B adrenergic agonists (B1/2) are used for —

A

B>a receptors
B1=B2

CHF → B1 increases cardiac contractility and CO

B2 activation causes brochodilation, used to treat asthma

isoproterenol (isuprel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

isoproterenol (isuprel) is a —

A

Nonselective β Adrenergic Agonists (β1/2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

isoproterenol (Isuprel) is used to treat

A

CHF: B1 activation causes increased cardiac contractility and increased CO

asthma: B2 activation leads to bronchodilation

B1/2 have B>a, with B1=B2

Nonselective β Adrenergic Agonists (β1/2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

B1 agonist is used to treat

A

short term CHF

increases force of cardiac contraction but does not effect HR

dobutamine (dobutrex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

dobutamine (dobutrex) is what type of drug

A

B1 adrenergic agonist

increases force of cardiac contraction but has minimal effect on HR

treatment of short term CHF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

— are b2 adrenergic agonists

A

albuterol (Salbutamol)
Metaproterenol

B2>B1 at low dose

β2-stimulation ↑ bronchodilation and other smooth muscle relaxation

prevent premature labor by relaxing uterine smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

albuterol is used for

A

β2 Adrenergic Agonists

B2>B1 at low dose

β2-stimulation increased bronchodilation and other smooth muscle relaxation

Also used to prevent premature labor by relaxing uterine smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

if you give high dose albuterol what will happen

A

spillover to B1 receptors

albuterol is a B2 agonist that causes bronchodilation and other smooth muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

— is a B3 Adrenergic Agonists

A

myrbetric (mirabegron)

B3 receptors are in brown fat, β3 receptor stimulation leads to increased lipolysis (fat breakdown)

B3 are also in bladder can be used to treat overactive bladder (OAB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

myrbetric (mirabegron) is what type of drug

A

β3 Adrenergic Agonists

used to treat overactive bladder

Sympathetic action on bladder causes relaxation of detrusor muscle and therefore a decrease in urge to urinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what does myrbetric(mirabegron) do

A

Sympathetic action on bladder causes relaxation of detrusor muscle and therefore a decrease in urge to urinate

B3 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how does tyramine and amphetamines get into the neuron?

A

presynaptic plasma membrane transporters

these are indirectly acting synpathomimetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
why dont ‘Indirectly acting’ sympathomimetics induce release of EPI from Adrenal gland?
indirectly acting symoathomimetics need to be transported into the cell by receptor: they then increase NE release adrenal gland chromaddin cells do not have a way to reuptake EPI ## Footnote tyramine and amphetamines are indirectly acting sympathomimetics that cause release of NE in nerve
26
indirectly acting sympathomimetics will be transported into the nerve terminal and cause
inreased release of endrogenous catecholamines **(NE)** ## Footnote tyramine and amphetamine
27
what are three catecholamine reuptake inhibitors
cocaine imipramine (impril) amitryptyline (amitril) allow NE,DA and serotonin to stay in synapse for longer, acts as **antidepressants**
28
how do reuptake inhibitor sympathomimetics work?
allow NE,DA and serotonin to stay in synapse for longer, acts as **antidepressants** cocaine imipramine (impril) amitryptyline (amitril)
29
how do mixed acting sympathomimetics work?
Cause release of endogenous catecholamines and ALSO bind directly to adrenergic receptors **ephedrine** Adverse effect: Potential hypertension and cardiac arrhythmias
30
ephedrine
mixed acting sympathomimetics Cause release of endogenous catecholamines and ALSO bind directly to adrenergic receptors can cause: increase **HTN**, decreased bladder sphincter incompetence, increased **bronchodilation** for treatment of asthma Adverse effect: Potential hypertension and cardiac arrhythmias
31
sudafed (pseudoephedrine) is a ---
mixed acting sympathomimetic Cause release of endogenous catecholamines and ALSO bind directly to adrenergic receptors can also be used to make **meth**
32
phenylephrine (sudafed-PE)
is a mixed acting sympathomimetic Cause release of endogenous catecholamines and ALSO bind directly to adrenergic receptors can not be used to make meth!
33
what does guanethidine do?
decreases NE release from nerve terminal guanethidine accumulates and replaces NE in vesicle High doses cause **TRIPHASIC** effect (1) Transient hypertension due to displaced NE (2) Drop in BP due to decrease NE release (3) Progressive drop in BP and cardiac output **used an an anti-hypertensive** ## Footnote Gua**NE**thidine prevents NE (norepinephrine) release
34
bretylium
blocks transmitted release by stopping release of NE vesicles different from guanethidine which accumulates and replaces NE in vesicle No BBB cross no affect on EPI release form adrenal medulla cause it needs **plasma membrane transporter** to get into nerve
35
clonidine
a2 agonist binds to a2 on presynaptic nerve, which **stops NE release**
36
reserpine
Blocks the uptake of DA and NE into synaptic vesicles by VMAT Does **not** require transporter to enter cells may also cause lower EPI in adrenal gland long acting tranquilizer in horses
37
--- blocks DA and NE uptake by VMAT into vesicles and does not need transporter to get into cells
reserpine leads to decreased NE, cause cytoplasmic NE will get broken down by MAO can also decrease EPI in adrenal gland
38
⍺-methyl-DOPA
false transmitter gets into cell without transporter cell thinks it is a normal DOPA and turns it into a-methyl-NE and released in the vesicle with normal NE a-methyl-NE will not bind as strongly to a1 but will also bind to a2 autoreceptors→ decreases release of NE from the cell a-methyl-dopa will use up the enzymes that usually make NE, will lead to smaller amount of NE released
39
--- is a false transmitter release
**α−methyl-DOPA** gets into cell without transporter cell thinks it is a normal DOPA and turns it into a-methyl-NE and released in the vesicle with normal NE → a-methyl-dopa will use up the enzymes that usually make NE, will lead to smaller amount of NE released a-methyl-NE will not bind as strongly to a1 but will also bind to a2 autoreceptors→ decreases release of NE from the cell
40
what are two things that block NE synthesis in the cell
α-CH3-p-tyrosine NE at high doses
41
--- inhibits tyrosine hydroxylase enzyme
α-CH3-p-tyrosine
42
--- are MAO inhibitors
pargyline moclobemide Used as **antidepressant**. It blocks degradation of DA and Serotonin in CNS too
43
what is cheese syndrome
thyramine is found in cheese and wine, is usually degraded by MAO if you use antidepressents like pargyline and moclobemide which **inhibit MAO**, can lead to build up of thyramine can lead to **hypertensive crisis**
44
5 uses of a- adrenergic receptor blockage
hypertension: decreased a1 vasoconstiction leads to **decreased peripheral resistance** **CHF**: lower arterial pressure improved CO peripheral vascular disease (raynauds) **benign prostatic hyperplasia**: decreases tone of prostate and urethral sphincter allows urinartion **shock**: decrease shock mediated vasoconstriction to increase organ perfusion and fluid replacement
45
--- are irreversible ⍺ receptor blockers
dibenamine phenoxybenzamine
46
phenoxybenzamine and dibenamine are --- and work ---
irreversible ⍺ receptor blockers will bind nonselectively to a1 and a2 and break receptors will need to wait for body to make new a1 or a2 receptors
47
--- is a reversible ⍺ receptor blocker
phentolamine (regitin)
48
how does phentolamine (regitin) work
reversible ⍺ receptor blocker a1=a2 if you **block a2 autoreceptor** that causes **increased release of NE**, which will trigger B1 in the heart and can lead to **tachycardia**
49
prazosin (minipress)
selective ⍺1 blocker a1>>a2 will block a1= decrease BP does not affect a2 at low dose so no extra release of NE and no tachycardia (this is what happens with reversible ⍺ receptor blocker, phentolamine (regitin)
50
tamsulosin (flomax)
selective ⍺1 blocker works on α1A- in urinary tract used to improve urinartion with men you have Benign Prostatic Hyperplasia (BPH) → relaxes muscle
51
yohumbine
selective ⍺2 blocker (only 40:1 a2>a1= high spill over) will block a2 which causes increase of NE relased this leads to increased HR and vasocontraction down stream used to **reverse xylazine induced sedation**
52
yohimbine will reverse ---
xylazine-induced sedation yohimbine is a ⍺2 blocker xylazine is a ⍺2 agonist
53
side effects of ⍺ receptor blockage
Postural Hypotension * Block of α1 -mediated reflexive vasoconstriction upon standing → venous pooling → syncope reflexive trachycardia * a2 block will increase NE and cause tachycardia through B1 nasal stuffiness * Block sympathetic tone on vessels in the nose leasing to increased in fluid leakage
54
beta blockers are used for
**Afib** **HTN**- will decrease BP **Angina**: **Anxiolytic**: stop tremors and anxiety **glaucoma**: decrease production of aqueous humor in the eye
55
propranolol(inderal)
non selective B blocker B1=B2 **decreases** HR, contractility and CO **Membrane stabilization** effect at high doses large withdrawal and rebound effect
56
propranolol (inderal) withdrawal effect
non-selective B blocker
57
pindolol (calvisken)
nonselective **B blocker** **partial agonist**: less withdrawal syndrome, less reduction in heart rate, but at high dose will cause increased HR,BP and brochodilation
58
timolol (timoptic)
B blocker nonselective B1=B2 less membrane stabilization used for **wide angle glaucoma**
59
metoprolol (lopressor)
selective B1 blocker As potent as propranolol at β1 but 100X less potent at β2 Little effect on adrenergic β2 -mediated effects **Cardioselective cause hitting B1 not B2**
60
butoxamine
selective B2 blocker Selective for blocking smooth muscle relaxation No pronounced cardiac effects (**No β1 action)**
61
side effects of B blocker
cardiac failure: in CHF patients bradycardia from decreased SYM to SA node Bronchial asthma: cause bronchoconstriction diabetics using oral hypoglycemics: B2 is needed to release EPI which causes release of glucose from liver, B blocker would cause hypoglycemic shock
62
63
64
65